Chemosensitivity in vitro to 2-chlorodeoxyadenosine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in previously unexposed cases of chronic lymphocytic leukemia.
暂无分享，去创建一个
[1] O. Kallioniemi,et al. Frequent loss of the 11q14‐24 region in chronic lymphocytic leukemia: A study by comparative genomic hybridization , 1997, Genes, chromosomes & cancer.
[2] F. Morabito,et al. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B‐cell chronic lymphocytic leukemia , 1997, Cancer.
[3] W. Hiddemann,et al. Purine analogs in the treatment of chronic lymphocytic leukemia. , 1997, Leukemia.
[4] L. Bergmann. Present status of purine analogs in the therapy of chronic lymphocytic leukemias. , 1997, Leukemia.
[5] J. Vilpo,et al. Selective toxicity of vincristine against chronic lymphocytic leukaemia in vitro , 1996, The Lancet.
[6] A. G. Bosanquet,et al. Novel ex vivo analysis of nonclassical, pleiotropic drug resistance and collateral sensitivity induced by therapy provides a rationale for treatment strategies in chronic lymphocytic leukemia , 1996 .
[7] K. Lee,et al. Comparison of antitumor activities of 2-chlorodeoxyadenosine and 9-beta-arabinosyl-2-fluoroadenine in chronic lymphocytic leukemia and marrow cells in vitro. , 1995, Leukemia.
[8] S. O'brien,et al. Advances in the biology and treatment of B-cell chronic lymphocytic leukemia , 1995 .